Rossari Biotech Limited (ROSSARI) — Capital Reinvestment Ratio
Rossari Biotech Limited (ROSSARI) has a Capital Reinvestment Ratio of 1.15x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs1.37 Billion) in capital expenditures (Rs1.59 Billion). See debt-free asset ratio of Rossari Biotech Limited to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Rossari Biotech Limited Capital Reinvestment Ratio (2017–2025)
This chart tracks Rossari Biotech Limited's Capital Reinvestment Ratio across 9 annual periods. Check cash flow reinvestment rate of Rossari Biotech Limited to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Rossari Biotech Limited (2017–2025)
Year-by-year Capital Reinvestment Ratio for Rossari Biotech Limited from 2017 to 2025. For live market cap and broader valuation context, see Rossari Biotech Limited market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.15x | Rs1.37 Billion | Rs1.59 Billion | ▼ -62.0% |
| 2024 | 3.04x | Rs432.55 Million | Rs1.31 Billion | ▲ +1306.9% |
| 2023 | 0.22x | Rs1.52 Billion | Rs328.76 Million | ▼ -83.4% |
| 2022 | 1.30x | Rs293.58 Million | Rs382.25 Million | ▲ +7.1% |
| 2021 | 1.22x | Rs477.67 Million | Rs580.84 Million | ▼ -12.2% |
| 2020 | 1.39x | Rs548.28 Million | Rs759.71 Million | ▲ +124.2% |
| 2019 | 0.62x | Rs711.77 Million | Rs439.91 Million | ▲ +13.5% |
| 2018 | 0.54x | Rs255.69 Million | Rs139.25 Million | ▼ -34.6% |
| 2017 | 0.83x | Rs46.95 Million | Rs39.12 Million | — |